Research Articles
Digital Alchemists: How Software is Forging the Future of Medicine
Exploring how computational software is revolutionizing drug discovery and medicinal chemistry through advanced molecular modeling and AI.
The Living Factory: How Synthetic Biology is Rewriting the Rules of Drug Discovery and Development
Explore how synthetic biology is revolutionizing drug discovery through engineered biological systems, living factories, and intelligent therapeutics.
The Secret Medicine Chest Inside Plants: How Endophytes Are Revolutionizing Drug Discovery
Exploring the untapped potential of endophytes - microbial symbionts that produce bioactive compounds with antimicrobial, anticancer, and neuroprotective properties.
Taming the Trifluoromethyl Beast: Simpler Paths to Powerful Molecular Building Blocks
Breakthrough methods for straightforward synthesis of N-trifluoromethyl amides, carbamates, thiocarbamates and ureas in drug discovery and materials science.
The Catalyst: How Jay Bradner's Open-Source Revolution is Rewriting Drug Discovery
Explore how physician-scientist Jay Bradner pioneered open-source drug discovery by sharing breakthrough cancer molecules, accelerating treatments worldwide.
Chemical Genomics: Decoding Life's Blueprint to Defeat Disease
Exploring how chemical genomics is revolutionizing drug discovery and disease treatment through systematic gene-chemical interaction mapping.
The Chemogenomics Revolution: Decoding Life's Molecular Conversations
Exploring the past, present and future of chemogenomics - the discipline mapping interactions between small molecules and biological targets to accelerate drug discovery.
Molecular Mavericks: How Ancient Plant Compounds Sparked a Drug Revolution
Exploring how ancient plant compounds called chalcones are being transformed into next-generation drugs to combat antibiotic resistance and cancer.
The Digital Hunt for Leishmaniasis Drugs: How Computer Models Are Revolutionizing Parasite Warfare
Exploring how in-silico methods are transforming the search for new antileishmanial drugs through computational biology and AI-powered screening.